<DOC>
	<DOCNO>NCT01627613</DOCNO>
	<brief_summary>The purpose study assess effect orally inhale AP301 alveolar liquid clearance ALI ( acute lung injury ) patient purpose assess treatment associate change extravascular lung water ( EVLW ) within 7 day treatment .</brief_summary>
	<brief_title>Study Intensive Care Patients Investigate Clinical Effect Repetitive Orally Inhaled Doses AP301 Alveolar Liquid Clearance Acute Lung Injury</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Lung Injury</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>age ≥ 18 intubate mechanically ventilated male female patient Intensive Care Units Department Anesthesia , General Intensive Care Pain Control meet criterion ALI ( define AmericanEuropean Consensus Conference ALI/ ARDS ) : Onset ALI within 48 hour Bilateral infiltrates see frontal chest radiograph PCWP ≤ 18 mm Hg clinical evidence leave atrial hypertension paO2/ FiO2 ratio ≤ 300 mm Hg EVLW PiCCO® screen ≥ 8 ml/PBW Meeting criterion extensive hemodynamic monitoring accord investigator discretion ICU Patients mechanically ventilate stable condition least 8 hour Negative pregnancy test adequate contraception female patient childbearing potential Informed consent : For patient temporarily unable consent ( e.g . comatose patient ) subsequent inform consent provide . History clinically relevant allergy idiosyncrasy AP301 inactive ingredient ( ) investigational product Brainstem death screen Current evidence septic shock define Surviving Sepsis Campaign ( Presence acute organ dysfunction secondary infection plus hypotension systolic blood pressure &lt; 90 mm Hg mean arterial pressure ( MAP ) &lt; 70 mm Hg le one hour reverse fluid resuscitation ) Neutrophil count &lt; 0.3 x 109 L Patients immunosuppression : high dose steroid ( &gt; 80 mg Prednisolone /d ; &gt; 300 mg hydrocortisone / ) , cancer treatment ( chemotherapy biological ) therapy immunosuppressive agent organ transplantation within 2 week BMI &lt; 18.5 &gt; 35 Cardiogenic pulmonary edema diagnose echocardiography pulmonary artery catheter Pregnancy / lactation intention fall pregnant time course study Women childbearing potential well men procreative capacity use adequate contraception Participation interventional drug trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>